#USA #New York #orthopedic care #Patient Outcomes #Force Therapeutics

Force Therapeutics Celebrates 2025 Research Impact

Force Therapeutics proudly commemorates a significant milestone in research achievements in 2025. This landmark year was made possible through collaborative efforts with healthcare partners across the nation, reflecting a concerted push towards transforming orthopedic care through innovative research initiatives.

By leveraging the comprehensive outcomes data and research infrastructure provided by Force Therapeutics, these partner organizations have been able to produce groundbreaking research aimed at optimizing orthopedic practices. The aforementioned collaboration underscores an essential aspect of modern medicine—the role of real-world data in shaping patient care and clinical insights.

Throughout the year, numerous research initiatives conducted in collaboration with Force Therapeutics were published or presented at esteemed academic and clinical forums. Below are highlights that showcase the expanding role of real-world digital care data in the future of orthopedics:

1. Current Concepts in Joint Replacement (CCJR) 2025 Meeting: A poster presented questioned whether total hip arthroplasty offers less pain compared to total knee arthroplasty, shedding light on patient experiences and outcomes.
2. FrameWORX Conference at Grace College: Research discussed the impact of stacked patient comorbidities on 90-day readmissions after joint procedures, providing crucial insights into patient management post-surgery.
3. Journal of Orthopedic Reports: A research article revealed preoperative predictors of unplanned emergency department visits following total hip arthroplasty.
4. Journal of the American Academy of Orthopedic Surgeons (AAOS): Findings indicated that patient satisfaction following total hip arthroplasty may reach an impressive 95%.
5. American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting: A presentation highlighted a trend where patients are more likely to seek subsequent contralateral total joint arthroplasty when preoperative pain levels are reduced.
6. National Association of Orthopedic Nurses (NAON) Congress: Discussions revealed a satisfaction rate of nearly 90% among total knee arthroplasty patients, showcasing improvements over time.
7. Western Orthopedic Association Annual Meeting: An e-poster illustrated how digital patient engagement meets Medicare's Patient-Reported Outcomes (PRO) requirements after total hip and knee arthroplasties.
8. Northeast Arthroplasty Conference: Multiple posters were presented, highlighting patient satisfaction and predictors of emergency visits, evidencing the ongoing commitment to enhancing patient care metrics.

Bronwyn Spira, CEO and Founder of Force Therapeutics, commented, "These publications attest to our partners' dedication to their patients. Their clinical leadership, academic curiosity, and commitment to advancing care turn data into insights and those insights into tangible impact.” This statement resonates strongly within the healthcare community, emphasizing the vital role of collaboration in research and patient care.

Force Therapeutics is dedicated to fostering research that strengthens real-world practice and enhances patient experiences. The organization remains energized by the daily achievements of its partners, revealing that when digital care is designed with clinical integrity, the outcomes can be remarkably beneficial. As we progress into new phases of healthcare innovation, the insights gained from these collaborative efforts are set to redefine the landscape of orthopedic care for years to come.